Q1 2016 · —
Revenue—
Net Income-$5.91M-$5.91M no prior Q1 2015 on file
EPS Diluted-$21.51-$21.51 no prior Q1 2015 on file
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2015 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Spero Therapeutics, Inc. · CIK 1701108 · Engraved from SEC EDGAR